Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

The British Neuroscience Association (BNA) has awarded Angela Vincent, FRS the 2016 Outstanding Contribution to British Neuroscience Award.

The award, launched in 2000, recognises one individual each year who has made a significant impact in their field of work in neuroscience, neurology or mental health research; and who, in addition to international calibre research, has also influenced the advancement of neuroscience by participation on high-level committees and work groups in the UK and beyond.

Angela Vincent is a world-class neuroimmunologist, who has created a step change in the diagnosis and treatment of autoimmune disorders, including myasthenia gravis and encephalitis. She is recognised as one of the pioneers in this area of neuroscience and her active translational research has led to the discovery of new brain and neuromuscular diseases. Her work has paved the way for new and improved therapy in some cases, where none was previously available.

Importantly Angela has been an outstanding role model to other women in the biosciences and has always been extremely supportive of young researchers, doing everything she could to help advance their careers.

The award will be presented at the BNA Christmas Symposium in London on 14 December.

Read more about the impact of Angela's work.

Similar stories

Attention and memory deficits persist for months after recovery from mild COVID

Researchers from Oxford’s Nuffield Department of Clinical Neurosciences and Department of Experimental Psychology have shown that people who have had COVID but don’t complain of long COVID symptoms in daily life nevertheless can show degraded attention and memory for up to six to nine months.

New spinout company: Human-Centric Drug Discovery

Human-Centric Drug Discovery is a new Oxford University spinout company from Professor Zameel Cader's lab.

Funding received for research into Motor Neuron Disease

A £210,000 donation from the Alan Davidson Foundation has been made to our Department to advance our world-leading research into Motor Neuron Disease. The funding will support a project manager to deliver an innovative research project using the genetic causes of MND to develop approaches to early diagnosis.

New Year's Honours for Professor Irene Tracey

Professor Irene Tracey FMedSci, MAE, Professor of Anaesthetic Neuroscience and Warden of Merton College, has been appointed CBE for services to medical research.

Protein test could lead to earlier and better diagnosis of Parkinson’s

Scientists have observed the clumping of alpha-synuclein in the cerebrospinal fluid taken from people with Parkinson's. The findings offer hope that a pioneering new clinical test could be developed to diagnose Parkinson's correctly in its early stages.

Nine new Professors

Many congratulations to the following members of our Department who have been awarded the title of Professor in the recent Recognition of Distinction round.